FDA & COVID-19: Discussion on Clinical Studies and Market Access in the United States | McDermott Skip to main content

FDA & COVID-19: Discussion on Clinical Studies and Market Access in the United States

FDA & COVID-19: Discussion on Clinical Studies and Market Access in the United States

Überblick


Anisa Mohanty will be joining France Biotech to discuss legal and regulatory considerations when running clinical trials, managing supply chain risk, the FDA’s engagement strategies and more.

For additional information and to register, click here.

Mehr erfahren

New York, NY / In-person / October 16, 2025

HPE NYC 2025

Paris, France / Event Sponsoring / October 7-8, 2025

HTID | Healthtech Innovation Days 2025

San Diego, California / In-person / July 1, 2025

AHLA Annual Meeting Reception 2025

Paris, France / In-person / April 2, 2025

European Health & Life Sciences Symposium 2025

Saint-Étienne, France / Externe Vorträge / March 21, 2025

What Impact Will The Pharmaceutical Package Have on The French Pharmaceutical Industry?

Brussels, Belgium / Externe Vorträge / March 11, 2025

Inaugural European Summit | Women Leaders in Life Sciences Law